| Date Filed | Type | Description |
| 04/16/2019 |
GN
| Investor Expectations to Drive Momentum within uniQure N.V., Aflac, ANI Pharmaceuticals, MaxLinear, ZAGG, and Aqua America — Discovering Underlying Factors of Influence |
| 02/13/2019 |
GN
| Factors of Influence in 2019, Key Indicators and Opportunity within Amkor Technology, U.S. Silica, Steven Madden, Rowan Companies, SunOpta, and ANI Pharmaceuticals — New Research Emphasizes Economic Growth |
| 08/27/2018 |
GN
| Recent Analysis Shows KalVista Pharmaceuticals, IZEA, Sonic Automotive, Catabasis Pharmaceuticals, ANI Pharmaceuticals, and Clovis Oncology Market Influences — Renewed Outlook, Key Drivers of Growth |
| 06/25/2018 |
GN
| Market Trends Toward New Normal in EnviroStar, Rowan Companies, Del Taco Restaurants, ANI Pharmaceuticals, Infinity Property and Casualty, and Viacom — Emerging Consolidated Expectations, Analyst Ratings |
| 05/07/2018 |
GN
| Market Trends Toward New Normal in Viacom, Nutanix, ANI Pharmaceuticals, PACCAR, Cabot Oil & Gas, and Box — Emerging Consolidated Expectations, Analyst Ratings |
| 03/05/2018 |
GN
| Detailed Research: Economic Perspectives on Lear, MYOS RENS Technology, Dollar Tree, Halliburton, Waters, and ANI Pharmaceuticals — What Drives Growth in Today's Competitive Landscape |
| 11/02/2017 |
GN
| Report: Developing Opportunities within Echelon, NII Holdings, ANI Pharmaceuticals, Zion Oil & Gas, vTv Therapeutics, and Sears Holdings – Future Expectations, Projections Moving into 2018 |
| 04/04/2012 |
PRN
| Deadline Approaching: The Law Firm of Levi & Korsinsky Notifies Investors With Losses on Their Investment in BioSante Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of April 6, 2012 to Seek a Lead Plaintiff Position |
| 07/21/2011 |
BW
| BioSante Pharmaceuticals Signs Melanoma Vaccine License |
| 06/07/2011 |
BW
| BioSante Pharmaceuticals, Inc. To Present at Jefferies Global Healthcare Conference |
| 05/18/2011 |
BW
| BioSante Pharmaceuticals, Inc. To Present at Two Upcoming Investor Conferences |
| 05/10/2011 |
BW
| BioSante Pharmaceuticals Reports First Quarter Financial Results and Recent Developments |
| 04/27/2011 |
BW
| BioSante Pharmaceuticals, Inc. To Present at the Deutsche Bank Annual Health Care Conference |
| 04/18/2011 |
BW
| BioSante Pharmaceuticals Announces Pancreatic and Prostate Cancer Vaccine License |
| 04/13/2011 |
BW
| BioSante Pharmaceuticals Announces Teva New Drug Application for Bio-T-Gel™ |
| 04/11/2011 |
BW
| BioSante Pharmaceuticals, Inc. To Present at Future Leaders in the Biotech Industry Conference |
| 03/30/2011 |
BW
| BioSante Pharmaceuticals Completes Enrollment in Both Pivotal LibiGel® Phase III Efficacy Trials |
| 03/17/2011 |
MW
| Speculative Biotech Firms Remain Popular Takeover Targets |
| 03/16/2011 |
BW
| BioSante Pharmaceuticals Reports Financial Results for 2010 and Clinical Development and Business Highlights |
| 03/09/2011 |
BW
| BioSante Pharmaceuticals Closes $25.1 Million Registered Direct Offering |
| 03/04/2011 |
BW
| BioSante Pharmaceuticals to Raise $25.1 Million in Registered Direct Offering |
| 03/03/2011 |
BW
| BioSante's Pancreas Cancer Vaccine Shows Survival Increase in Newly Published Study |
| 02/24/2011 |
BW
| BioSante Pharmaceuticals Completes Enrollment in LibiGel® Phase III Efficacy Trial |
| 02/22/2011 |
BW
| BioSante Pharmaceuticals, Inc. to Present at Citi Global Health Care Conference |
| 02/15/2011 |
BW
| BioSante Presents Data Showing Female Sexual Dysfunction is a Significant Unmet Medical Need |
| 02/14/2011 |
BW
| BioSante Pharmaceuticals Reports Positive LibiGel® Safety Data in Phase III Program |
| 02/14/2011 |
BW
| BioSante Pharmaceuticals, Inc. To Present LibiGel® Safety Study Update at BIO CEO & Investor Conference |
| 02/12/2011 |
BW
| BioSante Pharmaceuticals Reports Positive LibiGel® Safety Data in Phase III Program |
| 01/10/2011 |
MW
| Exciting Opportunities Emerge in Biotech Sector |
| 11/17/2010 |
BW
| BioSante Pharmaceuticals Sells Oncolytic Virus Technology to Cold Genesys, Inc. |
| 11/12/2010 |
BW
| BioSante Pharmaceuticals Reports Third Quarter 2010 Financial Results |
| 10/26/2010 |
BW
| BioSante Pharmaceuticals, Inc. To Present at Two Upcoming Investor Conferences |
| 10/25/2010 |
BW
| BioSante Pharmaceuticals Reports Positive LibiGel® Data Monitoring Committee Recommendation |
| 10/18/2010 |
BW
| BioSante Pharmaceuticals Reaches Key LibiGel® Safety Study Enrollment Target |
|